Correlation Between Unicorn Technologies and Clal Biotechnology
Can any of the company-specific risk be diversified away by investing in both Unicorn Technologies and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicorn Technologies and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicorn Technologies and Clal Biotechnology Industries, you can compare the effects of market volatilities on Unicorn Technologies and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicorn Technologies with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicorn Technologies and Clal Biotechnology.
Diversification Opportunities for Unicorn Technologies and Clal Biotechnology
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Unicorn and Clal is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Unicorn Technologies and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Unicorn Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicorn Technologies are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Unicorn Technologies i.e., Unicorn Technologies and Clal Biotechnology go up and down completely randomly.
Pair Corralation between Unicorn Technologies and Clal Biotechnology
Assuming the 90 days trading horizon Unicorn Technologies is expected to generate 0.9 times more return on investment than Clal Biotechnology. However, Unicorn Technologies is 1.12 times less risky than Clal Biotechnology. It trades about -0.06 of its potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.06 per unit of risk. If you would invest 4,390 in Unicorn Technologies on September 2, 2024 and sell it today you would lose (380.00) from holding Unicorn Technologies or give up 8.66% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Unicorn Technologies vs. Clal Biotechnology Industries
Performance |
Timeline |
Unicorn Technologies |
Clal Biotechnology |
Unicorn Technologies and Clal Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicorn Technologies and Clal Biotechnology
The main advantage of trading using opposite Unicorn Technologies and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicorn Technologies position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.Unicorn Technologies vs. Holmes Place International | Unicorn Technologies vs. Altshuler Shaham Financial | Unicorn Technologies vs. Bio Meat Foodtech | Unicorn Technologies vs. YD More Investments |
Clal Biotechnology vs. Bezeq Israeli Telecommunication | Clal Biotechnology vs. Brainsway | Clal Biotechnology vs. Mivne Real Estate | Clal Biotechnology vs. Photomyne |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |